We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.51B
AUM Growth
-$25.3M
Cap. Flow
-$166M
Cap. Flow %
-11.02%
Top 10 Hldgs %
21.48%
Holding
1,502
New
400
Increased
305
Reduced
321
Closed
403

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$11.8M
2
EDU icon
New Oriental
EDU
+$11.7M
3
LI icon
Li Auto
LI
+$10.4M
4
HES
Hess
HES
+$9.96M
5
ACMR icon
ACM Research
ACMR
+$7.73M

Sector Composition

Rank Sector Weight
1 Technology 14.24%
2 Consumer Discretionary 12.06%
3 Healthcare 10.13%
4 Industrials 10.12%
5 Energy 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TALK icon
1076
Talkspace
TALK
$878M
$47.5K ﹤0.01%
+18,700
New +$37.8K
CDE icon
1077
Coeur Mining
CDE
$18.6B
$46.3K ﹤0.01%
+14,197
New +$38.8K
ZVIA icon
1078
Zevia
ZVIA
$109M
$44.5K ﹤0.01%
22,160
EGHT icon
1079
8x8 Inc
EGHT
$325M
$43.5K ﹤0.01%
11,519
-15,427
-57% -$45.8K
NFGC
1080
New Found Gold
NFGC
$661M
$43.2K ﹤0.01%
+12,339
New +$46.7K
FREE
1081
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$42.3K ﹤0.01%
+12,400
New +$41.9K
STLN
1082
Starling Oncology, Inc. Common Stock
STLN
$610M
$40K ﹤0.01%
19,629
-30,240
-61% -$52.4K
GAN
1083
DELISTED
GAN Ltd
GAN
$37.8K ﹤0.01%
+23,918
New +$31.9K
BNKK
1084
Bonk Inc
BNKK
$8.56M
$35.1K ﹤0.01%
+286
New +$26.9K
LYEL icon
1085
Lyell Immunopharma
LYEL
$349M
$34K ﹤0.01%
+875
New +$31.5K
PGY icon
1086
Pagaya Technologies
PGY
$1.79B
$30.4K ﹤0.01%
+1,833
New +$29.9K
ERAS icon
1087
Erasca
ERAS
$6.21B
$29K ﹤0.01%
13,600
-700
-5% -$1.48K
ATAI icon
1088
AtaiBeckley Inc
ATAI
$2.68B
$25.3K ﹤0.01%
+17,952
New +$22.3K
PFIE
1089
DELISTED
Profire Energy, Inc
PFIE
$24.9K ﹤0.01%
13,742
-27,958
-67% -$52.5K
TGB
1090
Trekor Metals
TGB
$3.18B
$24.3K ﹤0.01%
+17,364
New +$21.3K
ASTLW icon
1091
Algoma Steel Group Warrant
ASTLW
$99.1K
$22.7K ﹤0.01%
12,313
AGEN
1092
Agenus
AGEN
$283M
$22.3K ﹤0.01%
+1,344
New +$22.3K
PGEN icon
1093
Precigen
PGEN
$2.52B
$22K ﹤0.01%
+16,393
New +$19.3K
WBX
1094
Wallbox
WBX
$82M
$20.7K ﹤0.01%
+592
New +$21.2K
SNDL icon
1095
CALL
Sundial Growers
SNDL
$315M
$17.1K ﹤0.01%
10,400
NBSE
1096
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$11.5K ﹤0.01%
15,550
PSNYW icon
1097
Polestar Automotive Holding ADS Class C-1
PSNYW
$398M
$3.97K ﹤0.01%
551
SRZNW icon
1098
Surrozen Inc Warrant
SRZNW
$8.86K
$478 ﹤0.01%
24,614
KPLTW
1099
DELISTED
Katapult Holdings Warrant
KPLTW
$212 ﹤0.01%
28,680
A icon
1100
Agilent Technologies
A
$41.7B
-2,121
Closed -$237K

Similar funds

Prelude Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Prelude Capital Management held 1,502 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management withdrew a net $166M in Q4 2023, closing 403 positions and reducing 321 holdings. Its most notable exit was Activision Blizzard, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in New Oriental worth $12.4M.

  • Prelude Capital Management's largest Q4 2023 buy was New Oriental: 168,713 shares worth $12.4M.
  • Prelude Capital Management added most to Vipshop in Q4 2023, an estimated $11.8M increase.
  • Prelude Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $7.3M.
  • Prelude Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $20.8M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $1.51B portfolio in Q4 2023.
  • Prelude Capital Management opened 400 new positions and closed 403 in Q4 2023.
  • Prelude Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.51B.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.